miR-449a has been reported to suppress tumor cell proliferation/growth and survival by targeting CDK6, CDC25A, Sirt1, HDAC1, cyclinD1, WISP2, and c-Met [11–14]. The gene discussed is HDAC1; the disease is neoplasm.